Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z009076 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
administering PROQUAD and VARIVAX after experiencing a temperature excursion; no adverse event; This spontaneous report was received from a Medical Assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of an improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) solution for injection, lot #Z009076, expiration date: 15-Nov-2026 (strength, dose, route and site of administration not provided) for prophylaxis, which was reconstituted with sterile diluent (strength, dose, formulation, route and site of administration, lot # and expiration date not provided). The vaccine was administered after a temperature excursion (TE) at -13.4 degree Celsius (C) for 9 hours and 32 minutes, with a previous TE at -12.9 degree C for 2 hours and 22 minutes (product storage error). No additional adverse event was reported for the patient (no adverse event). No additional information provided. This is one of several reports received from the same reporter.